AMH
BIOSW

Apollo Management Holdings’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Apollo Management Holdings’s Portfolio BIOSW Stock Details BIOSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-125,000
Closed -$18.4K – 123
2023
Q2 		$18.4K Hold
125,000
– – ﹤0.01% 101
2023
Q1 		$11.9K Hold
125,000
– – ﹤0.01% 152
2022
Q4 		$12K Hold
125,000
– – ﹤0.01% 170
2022
Q3 		$10K Hold
125,000
– – ﹤0.01% 221
2022
Q2 		$17K Hold
125,000
– – ﹤0.01% 241
2022
Q1 		$29K Buy
+125,000
New +$32.5K ﹤0.01% 343

Other funds holding BIOSW

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Apollo Management Holdings's BIOSW Position: Q3 2023 in Review

Apollo Management Holdings sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q3 2023, closing a stake of 125,000 shares — an estimated $18.4K sold.

Apollo Management Holdings first reported a position in BIOSW in Q1 2022 and held it in 6 quarters. The position peaked at $29K in Q1 2022. 46 funds tracked by Wall St. Rank hold BIOSW as of Q3 2023.

  • Apollo Management Holdings reported no remaining BioPlus Acquisition Corp. Warrants position as of Q3 2023 after selling out during the quarter.
  • Apollo Management Holdings sold 125,000 BioPlus Acquisition Corp. Warrants shares in Q3 2023, an estimated $18.4K.
  • Apollo Management Holdings first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 6 quarters.
  • Apollo Management Holdings's BioPlus Acquisition Corp. Warrants position peaked at $29K in Q1 2022.
  • 46 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q3 2023.

Based on Apollo Management Holdings's 13F filing for Q3 2023, filed 14 Nov 2023.